These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25852799)

  • 1. Collateral benefits arising from mass administration of azithromycin in the control of active trachoma in resource limited settings.
    Kigen G; Rotich J; Karimurio J; Rono H
    Pan Afr Med J; 2014; 19():256. PubMed ID: 25852799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass distribution of azithromycin for trachoma control is associated with short-term reduction in risk of acute lower respiratory infection in young children.
    Coles CL; Levens J; Seidman JC; Mkocha H; Munoz B; West S
    Pediatr Infect Dis J; 2012 Apr; 31(4):341-6. PubMed ID: 22173140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass distribution of azithromycin for trachoma control is associated with increased risk of azithromycin-resistant Streptococcus pneumoniae carriage in young children 6 months after treatment.
    Coles CL; Mabula K; Seidman JC; Levens J; Mkocha H; Munoz B; Mfinanga SG; West S
    Clin Infect Dis; 2013 Jun; 56(11):1519-26. PubMed ID: 23487375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal evaluation of three azithromycin distribution strategies for treatment of trachoma in a sub-Saharan African country, Mali.
    Schémann JF; Guinot C; Traore L; Zefack G; Dembele M; Diallo I; Traore A; Vinard P; Malvy D
    Acta Trop; 2007 Jan; 101(1):40-53. PubMed ID: 17239332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village.
    West SK; Munoz B; Mkocha H; Gaydos C; Quinn T
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1492-7. PubMed ID: 17389476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal.
    Fry AM; Jha HC; Lietman TM; Chaudhary JS; Bhatta RC; Elliott J; Hyde T; Schuchat A; Gaynor B; Dowell SF
    Clin Infect Dis; 2002 Aug; 35(4):395-402. PubMed ID: 12145722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and baseline data of a randomized trial to evaluate coverage and frequency of mass treatment with azithromycin: the Partnership for Rapid Elimination of Trachoma (PRET) in Tanzania and The Gambia.
    Stare D; Harding-Esch E; Munoz B; Bailey R; Mabey D; Holland M; Gaydos C; West S
    Ophthalmic Epidemiol; 2011 Feb; 18(1):20-9. PubMed ID: 21275593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of oral azithromycin versus topical tetracycline in mass treatment of endemic trachoma.
    Fraser-Hurt N; Bailey RL; Cousens S; Mabey D; Faal H; Mabey DC
    Bull World Health Organ; 2001; 79(7):632-40. PubMed ID: 11477966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions.
    Biebesheimer JB; House J; Hong KC; Lakew T; Alemayehu W; Zhou Z; Moncada J; Rogér A; Keenan J; Gaynor BD; Schachter J; Lietman TM
    Ophthalmology; 2009 Nov; 116(11):2047-50. PubMed ID: 19744717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there evidence for resistance of ocular Chlamydia trachomatis to azithromycin after mass treatment for trachoma control?
    West SK; Moncada J; Munoz B; Mkocha H; Storey P; Hardick J; Gaydos CA; Quinn TC; Schachter J
    J Infect Dis; 2014 Jul; 210(1):65-71. PubMed ID: 24446528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment coverage of mass administration of azithromycin among children aged 1-11 months in 21 districts of Kebbi state, Nigeria.
    Wamyil-Mshelia T; Madaki S; Isiyaku S; Shu'aibu J; Olobio NP; Aliero AA; Abdulsalam M; Taiwo J; McDickoh VJ
    Int Health; 2023 Dec; 15(Supplement_2):ii12-ii18. PubMed ID: 38048379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Operational comparison of single-dose azithromycin and topical tetracycline for trachoma.
    Bowman RJ; Sillah A; Van Dehn C; Goode VM; Muqit MM; Johnson GJ; Milligan P; Rowley J; Faal H; Bailey RL
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4074-9. PubMed ID: 11095598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Childhood Mortality After Mass Distribution of Azithromycin: A Secondary Analysis of the PRET Cluster-randomized Trial in Niger.
    O'Brien KS; Cotter SY; Amza A; Kadri B; Nassirou B; Stoller NE; Zhou Z; West SK; Bailey RL; Keenan JD; Porco TC; Lietman TM
    Pediatr Infect Dis J; 2018 Nov; 37(11):1082-1086. PubMed ID: 29561511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood mortality in a cohort treated with mass azithromycin for trachoma.
    Keenan JD; Ayele B; Gebre T; Zerihun M; Zhou Z; House JI; Gaynor BD; Porco TC; Emerson PM; Lietman TM
    Clin Infect Dis; 2011 Apr; 52(7):883-8. PubMed ID: 21427395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of effects of community intervention with antibiotics, facial cleanliness, and environmental improvement (A,F,E) in five districts of Ethiopia hyperendemic for trachoma.
    Ngondi J; Gebre T; Shargie EB; Adamu L; Teferi T; Zerihun M; Ayele B; King JD; Cromwell EA; Emerson PM
    Br J Ophthalmol; 2010 Mar; 94(3):278-81. PubMed ID: 19897474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anthropometric indices of Gambian children after one or three annual rounds of mass drug administration with azithromycin for trachoma control.
    Burr SE; Hart J; Edwards T; Harding-Esch EM; Holland MJ; Mabey DC; Sillah A; Bailey RL
    BMC Public Health; 2014 Nov; 14():1176. PubMed ID: 25407464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass treatment of trachoma with azithromycin 1.5% eye drops in the Republic of Cameroon: feasibility, tolerance and effectiveness.
    Huguet P; Bella L; Einterz EM; Goldschmidt P; Bensaid P
    Br J Ophthalmol; 2010 Feb; 94(2):157-60. PubMed ID: 19692356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilot study of the use of community volunteers to distribute azithromycin for trachoma control in Ghana.
    Solomon AW; Akudibillah J; Abugri P; Hagan M; Foster A; Bailey RL; Mabey DC
    Bull World Health Organ; 2001; 79(1):8-14. PubMed ID: 11217675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. To eliminate trachoma: Azithromycin mass drug administration coverage and associated factors among adults in Goro district, Southeast Ethiopia.
    Feyisa T; Bekele D; Tura B; Adem A; Nugusu F
    PLoS Negl Trop Dis; 2022 Jun; 16(6):e0010169. PubMed ID: 35759466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Annual Versus Biannual Mass Azithromycin Distribution and Malaria Parasitemia During the Peak Transmission Season Among Children in Niger.
    Oldenburg CE; Amza A; Kadri B; Nassirou B; Cotter SY; Stoller NE; West SK; Bailey RL; Porco TC; Keenan JD; Lietman TM; Gaynor BD
    Pediatr Infect Dis J; 2018 Jun; 37(6):506-510. PubMed ID: 29088030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.